AssetMark Inc
ORIC icon

AssetMark Inc’s Oric Pharmaceuticals ORIC Stock Holding History

AssetMark Inc’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$39.7K Hold
2,945
– – ﹤0.01% 1971
2026
Q2 		$31.9K Sell
2,945
-55
-2% -$499 ﹤0.01% 2014
2026
Q1 		$38K Hold
3,000
– – ﹤0.01% 1841
2025
Q4 		$24.5K Sell
3,000
-89
-3% -$1.02K ﹤0.01% 1938
2025
Q3 		$37.1K Buy
+3,089
New +$32.5K ﹤0.01% 1734

Other funds holding ORIC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Zweig-DiMenna Associates
Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

AssetMark Inc's ORIC Position: Q3 2026 in Review

AssetMark Inc held its Oric Pharmaceuticals (ORIC) position steady in Q3 2026 at 2,945 shares worth $39.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1971.

AssetMark Inc first reported a position in ORIC in Q3 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • AssetMark Inc held 2,945 shares of Oric Pharmaceuticals worth $39.7K as of Q3 2026.
  • AssetMark Inc left its Oric Pharmaceuticals share count unchanged in Q3 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1971 holding.
  • AssetMark Inc first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.